Clinical Pediatric Pneumonia Score in Critically Ill Children

Community Acquired Pneumonia Clinical Trial

Official title:

Development of a Clinical Pediatric Pneumonia Score in Critically Ill Children Admitted With Acute Respiratory Failure

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02139384
• Other study ID #: 5110327
• Status: Withdrawn
• Phase: N/A
• First received: May 8, 2014
• Last updated: April 24, 2017
• Start date: August 2012
• Est. completion date: January 2013

Study information

• Verified date: April 2017
• Source: Loma Linda University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to create a clinical pneumonia tool that can be used to predict the cause of community-acquired pneumonia, which is a lung infection that began outside of the hospital in critically ill children therefore limiting unnecessary antibiotic use. The investigators will enroll critically ill children admitted with acute respiratory failure and suspected pneumonia. Each patient will receive a clinical pneumonia score blinded from culture and respiratory viral panel results. All care after samples obtained will be at the discretion of the PICU team. The investigators believe that our clinical pneumonia scale with procalcitonin will accurately designate viral from bacterial etiologies.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: January 2013
• Est. primary completion date: January 2013
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 21 Years

Eligibility

Inclusion Criteria:

• All intubated pediatric patients

• Age 1 day to 21 years

• Admitted to the LLUCH PICU with suspected pneumonia for the next 6 months

• Have received antibiotics for less than 12 hours

• Have been intubated for less than 24 hours

• Patients must be English or Spanish speaking for consent purposes.

Exclusion Criteria:

• Patients who have received antibiotics for greater than 12 hours

• Patients who have been intubated for greater than 24 hours

• Patients who are unable to tolerate non-bronchoscopic bronchoalveolar lavage

Related Conditions & MeSH terms

• Community Acquired Pneumonia
• Critical Illness
• Pneumonia

Locations

Country	Name	City	State
United States	Loma Linda University Children's Hospital	Loma Linda	California

Sponsors (1)

Lead Sponsor	Collaborator
Loma Linda University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Can our proposed pneumonia score distinguish community acquired bacterial pneumonia from community acquired viral pneumonia		6 months